Avalo Therapeutics Inc. buy Bank of America Co.
Start price
12.06.26
/
50%
€0.041
Target price
12.06.27
€30.24
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 12.06.27. The prediction end date can be changed by Bank_of_America_Co_ at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Avalo Therapeutics Inc. | - | - |
| iShares Core DAX® | 0.855% | 0.389% |
| iShares Nasdaq 100 | -0.989% | -4.400% |
| iShares Nikkei 225® | -1.781% | -11.216% |
| iShares S&P 500 | 0.057% | 0.778% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Avalo Therapeutics Inc. diskutieren
Avalo Therapeutics (AVTX) is now covered by Bank of America Corporation. They set a "buy" rating and a $35.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat